Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.

Priller, J; Briley, E M; Mansouri, J; Devane, W A; Mackie, K; Felder, C C

Priller, J; Briley, E M; Mansouri, J; Devane, W A; Mackie, K; Felder, C C.

Affiliation

Priller J; National Institute of Mental Health, Laboratory of Cell Biology, Bethesda, Maryland 20892, USA.

Mol Pharmacol ; 48(2): 288-92, 1995 Aug.

Article in En | MEDLINE | ID: mdl-7651362

Subject(s)

8,11,14-Eicosatrienoic Acid/analogs & derivatives; Receptor, Cannabinoid, CB2; Receptors, Drug/agonists; 8,11,14-Eicosatrienoic Acid/pharmacology; Animals; Arachidonic Acid/metabolism; Arachidonic Acids/pharmacology; CHO Cells; Cannabinoids/metabolism; Cricetinae; Cyclohexanols/metabolism; Endocannabinoids; Humans; L Cells; Mice; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Drug/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Drug / Receptor, Cannabinoid, CB2 / 8,11,14-Eicosatrienoic Acid Limits: Animals / Humans Language: En Journal: Mol Pharmacol Year: 1995 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links